Chimerix, Inc(NASDAQ:CMRX) 
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candi...
Website: http://www.chimerix.com
Founded: 2000
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-10-18
P
O 0.87
H 0.89
L 0.85
C 0.88
V 48,553
10EMA 0.88
20EMA 0.88
60EMA 0.88
120EMA 0.88
250EMA 0.88